IN man and most mammals the concentration of calcium in the blood and body fluids remains almost constant under normal conditions, with only slight fluctuations. For the various cellular functions which are dependent on calcium, for example neuromuscular transmission, it is the ionized fraction of calcium (approximately 50 per cent of the total serum calcium level) which is important, and it is this fraction which is so carefully maintained at a constant level in the body fluids. In order to stabilize this level, an elaborate regulating mechanism is necessary, since there are many routes of entry into and exit from the blood available to calcium. Thus, calcium is added to the blood by absorption from the intestine and by resorption from bone, and leaves via formation of new bone, and by excretion into urine, fweces, sweat and milk. Changes in other components of the body fluids, protein, citrate and phosphate, affect the concentration of ionized calcium. The magnitude of all these factors will vary in response to growth, dietary intake, changes in activity, or pregnancy, and yet the net effect on concentration of ionized calcium is almost undetectable. Two factors of major importance in the regulation of serum levels of calcium are the parathyroid glands and vitamin D, and both of these are necessary to maintain normal levels.
Parathyroid Glands
If the parathyroid glands are removed, calcium in the serum falls rapidly to a level at which increased neuromuscular irritability occurs, with the syndrome of tetany. The parathyroid hormone raises the level of serum calcium, and a fall in this level is the principal stimulus to the secretion of hormone by the parathyroid glands. When the level of serum calcium exceeds normal, secretion of parathyroid hormone is suppressed until the level has returned to normal (McLean, 1957) . These effects have been clearly demonstrated by Copp and Davidson (1961) , who perfused a dog's parathyroid glands with blood of low or high calcium concentration, and showed that reciprocal changes in concentration of calcium in the systemic circulation resulted. The mechanism by which the parathyroid glands regulate their secretion in response to changing levels of serum calcium is quite unknown.
The parathyroid hormone has been purified from bovine glands, and its properties have been studied (Rasmussen and Craig 1961, 1962) . It is a protein of molecular weight approximately 9,000, composed of a single chain containing 76 to 83 amino-acid residues. It is antigenically pure, and antibodies have been prepared to it which provide the basis for a sensitive immunoassay (Berson, Yalow, Aurbach and Potts, 1963; Tashjian, Levine and Munson, 1963) . The most striking action of the hormone is that on the skeleton, which results in release of calcium into the blood. There is abundant evidence for this direct action of parathyroid hormone on bone, which has been reviewed by Munson (1960) , and strengthened by the striking experiments of Gaillard (1961) , who demonstrated resorption of bone in tissue culture in response to the hormone.
The mechanism by which parathyroid hormone increases resorption of bone is not known. The solubility of bone depends on pH of the surrounding fluid; as pH falls solubility increases, so that bone is resorbed. A possible mechanism for the action of parathyroid hormone on bone would therefore be through a lowering of pH of the fluid immediately in contact with the bone. This is the basis of the "acid theory" of action of parathyroid hormone (Neuman, Firschein, Chen, Mulryan and DiStefano, 1956; Firschein, Neuman, Martin and Mulryan 1959) . These workers showed that the concentration of citrate in blood obtained from the spongy bone of the dog's femur increased strikingly after injection of parathyroid hormone. They postulated that as a result of accumulation of citrate, pH of the fluids surrounding the bone falls, and increased resorption of bone then occurs. The citrate may also chelate some of the calcium released by bone resorption, and thus raise the gradient of ionic calcium between bone and the surrounding fluid. This theory has led to a large amount of research into the effect of parathyroid hormone on the production of organic acids by Ibone in vitro, and unfortunately there has been little agreement between different workers. Massive doses of parathyroid hormone have usually been necessary in order to produce an increase in levels of bone citrate, perhaps because of the relatively large amount of citrate present in bone in the basal state. Moreover, lactate is produced by bone in amounts approximately a hundred times greater than those of citrate in response to the hormone (Vaes and Nichols, 1961) , and it is therefore possible that lactate is of greater importance than citrate in producing resorption of ,bone. The conflicting results of in vitro studies have been reviewed by Firschein (1963) . Many workers still believe, however, that parathyroid hormone stimulates the release of citrate from bone, either by increasing its rate of formation (Ranney, 1960; Lekan, Laskin and Engel, 1960) , or by inhibiting its oxidation (Neuman and Dowse, 1961; Hekkelman, 1961) .
Although the skeleton is probably the most important site of action for parathyroid hormone it is not the only one. There is evidence that the hormone affects the transport of calcium in the kidney, gut and mammary gland. In the kidney, Talbot, Sobel, McArthur and Crawford (1954) first suggested that parathyroid hormone increases the reabsorption of filtered calcium by the renal tubules, so that the urinary clearance of calcium is reduced. Thus in hypoparathyroidism there may be normal or even high levels of urinary calcium in spite of hypocalcxmia, while in hyperparathyroidism, in spite of hypercalcemia, an abnormally raised urinary excretion of calcium is not always present. Kleeman, Bernstein, Rockney, Dowling and Maxwell (1961) showed that parathyroid extract produced a significant reduction in urinary calcium clearance at all levels of diffusible calcium, both in the majority of normal and in hypoparathyroid individuals.
Low clearances of calcium were noted in patients with primary hyperparathyroidism, and these rose after removal of the tumour. In carefully controlled studies on dogs, in which filtered loads of other ions were maintained constant, Widrow and Levinsky (1962) showed that urinary excretion of calcium fell after administration of parathyroid extract, although filtered calcium remained constant or increased. Similar findings have been reported in the rat by MacIntyre, Boss and Troughton (1963) . It has been shown (Komarkova, Vostal and Pacovsky 1960) (Karam, Harrison, Hartog and Fraser, 1961) (1959) showed that active transport of calcium by segments of rat duodenum in vitro was increased by parathyroid hormone. Balance studies in rats (Cramer, Suiker and Copp, 1961 ) indicated a marked increase in the net absorption of calcium in response to parathyroid hormone, provided that intake of calcium was adequate. In ThiryVella fistulas in dogs, Cramer (1963) showed that administration of the hormone increased absorption of calcium while parathyroidectomy resulted in a decrease. In man, Jaworski, Brown, Fedoruk and Seitz (1963) , using a tracer test of calcium absorption with calcium-45, demonstrated increased intestinal absorption of calcium in a patient with hyperparathyroidism.
In lactating rats, administration of parathyroid hormone results in a decrease of calcium concentration in the milk, while parathyroidectomy leads to increased secretion of calcium, suggesting that the parathyroid glands inhibit the secretion of calcium by the mammary gland (Toverud, 1963) .
It can be seen that all the effects of parathyroid hormone described on calcium transport lead to an increase in the amount of calcium in the blood and body fluids, so that through several different mechanisms the parathyroid glands effectively counter falling levels of serum calcium. From a teleological point of view, it seems most appropriate that calcium, made available through resorption of bone, is not all lost to the body through urinary or fwecal excretion but is retained in the blood. The parathyroid has been justly called "glande de protection du capital calcique" (Lichtwitz, 1961) . renal tubular reabsorption of inorganic phosphorus by a direct action on the renal tubules, resulting in an increase in urinary phosphorus and a falil of serum levels (Lavender, Pul-lman, Rasmussen and Aho, 1961; Horwith, Rich, Thompson and Rasmussen, 1961) . The decrease in serum levels of inorganic phosphorus tends to raise the level of calcium in the serum, by preventing precipitation of calcium phosphate in bone which occurs when the solubility product for calcium and phosphate is exceeded.
MacIntyre, Boss and Troughton (1963) have shown that in the rat, parathyroid hormone also influences transport of magnesium. Both parathyroid extract and pure bovine parathyroid hormone produce a fall in excretion of magnesium in the urine, while parathyroidectomy leads to a decrease in serum levels of magnesium. These workers suggest that a fall in serum level of magnesium stimulates the parathyroid glands, and the increased secretion of hormone is the cause of the hypercalcaemia which occurs in magnesium-deficient rats. Changes in concentration of magnesium may therefore upset the normal homeeostatic control of ca-lcium.
Calcitonin
Evidence has recently been presented in favour of the existence of a second parathyroid hormone, the action of which is opposite to that of the serum calcium-raising hormone. This second hormone, named calcitonin, was postulated as a result of perfusion experiments on the dog's thyroid and parathyroid glands with hypercalcemic blood (Copp, Cameron, Cheney, Davidson and Henze, 1962 (Copp and Cameron, 1961) . Copp concluded that the parathyroid glands secrete calcitonin in response to hypercalcemia and in this way restore the level of calcium to normal. Such a mechanism would provide a more rapid regulation than the simpler feedback mechanism depending on only one hormone.
The existence of a calcium-lowering factor secreted by the parathyroid in response to hypercalcaemia in the dog has been confirmed by Kumar, Foster and Maclntyre (1963) . In other animals, however, attempts to demonstrate calcitonin have not so far been successful . In man, the possibility that a calcium-lowering hormone exists has been suggested by the finding of unexplained hypocalcaemia in a patient with hyperplasia of the parathyroid glands (Frame, Fruchtman and Smith, 1962) (Carlsson and Lindquist, 1954; Nordin, 1960 (Clark, 1961) .
The action of vitamin D on the intestine has been thoroughly studied. There is abundant evidence that the vitamin facilitates the absorption of calcium, both in animals and in man.
In the rat, the principal site of action of vitamin D is the upper jejunum (Schachter, Kimberg, and Schenker, 1961) , and at least in this species its action is a direct one, without prior activation of the vitamin elsewhere in the body (Schachter, Kowarski and Finkelstein, 1964 (Litvak, Moldawer, Forbes and Henneman, 1958) . This may indicate either that vitamin D decreases the tubular reabsorption of calcium, as these workers suggested, or that tubular reabsorption is unaffected and the increased urinary calcium results from a greater filtered load. In a single experiment on a dog, however, Gran (1960a) observed that vitamin D raised serum levels of calcium and at the same time urinary excretion of calcium decreased. (Shelling, 1935) . This was soon shown to be incorrect, however, since vitamin D can maintain normal levels of serum calcium after removal of the parathyroid glands, and in other forms of hypoparathyroidism. TIhe vitamin allso produces its usuall effect on intestinal absorption of calcium in parathyroidectomized rats (Gran, 1960b) . Nevertheless, evidence for a functionall relationship between vitamin D and parathyroid hormone has continued to accumulate, and the earlier work has been reviewed by Neuman and Neuman (1958) . More recent experiments have shown that parathyroid hormone fails to raise the serum levels of calcium in rats with vitamin D deficiency, whose serum levels of calcium are low and of phosphorous high (Crawford, Gri,betz, Diner, Hurst and Castleman, 1957; Harrison, Harrison and Park, 1958; Marnay and Raoul, 1959 Rasmussen and colleagues also showed that the parathyroid glands of the vitamindeficient animals were far from inactive, since their removal resulted in a striking increase in serum levels of phosphorus. Evidently, the phosphaturic action of parathyroid hormone is unimpaired in these animals, and only the calcium-mobilizing activity is affected. It has repeatedly been observed, moreover, that the parathyroid glands are enlarged in vitamin Ddeficient animals, suggesting increased activity (Crawford and colleagues, 1957; Fraser, 1960a, 1960b) . It is of great interest that the dissociation of phosphorus-and calcium-mobilizing effects of parathyroid hormone in vitamin D-deficient rats is exactly what would be predicted from the observations on mitochondrial transport of calcium and phosphorus already described; in the absence of vitanin D, parathyroid hormone apparently influences phosphorus transport normally, but is without effect on mobilization of calcium, except in massive doses.
In vitamin D-deficient mice, a similar failure of parathyroid hormone to affect serum levels of calcium could not be demonstrated (Nichols and colleagues, 1963) but it has been suggested that the degree of vitamin deficiency may not have been severe enough to abolish sensitivity to parathyroid hormone (Rasmussen and colleagues, 1963) .
In man, the effects of vitamin D deficiency differ from those observed in the rat, in that serum levels of phosphorus are generally lower, while the 'levels of calcium may be normal or only slightly reduced. There is a considerable amount of evidence that vitamin D deficiency leads to secondary overactivity of the parathyroid glands, which tends to correct the hypocalcemia by mobilization of calcium from the skeleton, and at the same time reduces the serum levels of phosphorus by increasing urinary excretion. Evidence suggesting a state of hyperparathyroidism is provided by (a) the finding of increased calcium deposition in and resorption from bone in osteomalacia (Fraser, Harrison and Ibbertson, 1960; Nordin, Smith and Nisbet, 1964) ; (b) X-ray examination of the skeleton, which in vitamin D deficiency may show su(bperiosteal erosions and cysts typical of hyperparathyroidism (Davies, Dent and Willlcox, 1956) ; (c) the urinary excretion of phosphorus, whidh is normally raised as in hyperparathyroidism (Nordin and Fraser, 1960) . This increased excretion is suppressed by an infusion of calcium (Nordin and Fraser, 1954) , provided that the serum levels of calcium are raised above normal by the infusion and so suppress secretion of parathyroid hormone; (d) the parathyroid glands themselves, which are enlarged and in rare instances may develop adenomas (Fourman, 1960; Davies and colleagues, 1956 ).
The response of the parathyroid glands to vitamin D deficiency tends to return the serum calcium levels to normal at the expense of skeletal calcium, and so tetany is prevented. In some patients with vitamin D deficiency, however, this secondary hyperparathyroidism is inadequate or may even fail to occur, so that the serum levels of calcium fall, resulting in tetany. Bernstein, Kleeman, Dowling and Maxwell (1962) descrilbed a patient with steatorrheea and tetany, in whom administration of parathyroid hormone failed to raise the serum level of calcium, although increased urinary excretion of phosphorus did occur. A bone biopsy revealed no evidence of osteomalacia or of osteitis fibrosa. Only after partial treatment with vitamin D did parathyroid hormone produce the expected rise in serum levels of calcium. It appeared that in this patient there was unresponsiveness to the calciummobilizing effect of parathyroid hormone while vitamin D deficiency persisted, and that normal responsiveness to the hormone was restored by therapy with vitamin D. This phenomenon is similar to that observed in the vitamin Ddeficient rats. In children with rickets due to vitamin D deficiency, failure of parathyroid hormone to raise serum levels of calcium has also been noted (Jonxis, 1961; Steendijk, 1964 (Rasmussen and colleagues, 1963) .
In view of these observations, it seems that the action of small doses of vitamin D on the skeleton, demonstrated by Carlsson and Lindquist (1955) and Nordin (1960) (1961) suggested that vitamin D might be the fundamental calciumregulating factor, and that parathyroid hormone modified its actions. They pointed out that parathyroid hormone appeared later than vitamin D in the process of evolution and that paratlhyroid glands are albsent in the teleost fishes, which store large amounts of vitamin calcium-rich marine environment for a life on dry land necessitated a more efficiently regulated system for calcium homeeostasis, and the parathyroid glands evolved accordingly. A basic action of vitamin D, which affected transfer of energy in the mitochondria through DPN or TPN, was postulated: parathyroid hormone might then increase the activity of vitamin D and render its action more specific.
At the tiime this hypothesis was put forward there was little evidence to support it. It must have been gratifying to these workers, and of interest to all workers in the field of calcium metabolism, when the striking effects of vitamin D and parathyroid hormone on mitochondria were discovered. It now seems probable that vitamin D is indeed required for full expression of the effects of parathyroid hormone, and that these effects are produced at the mitochondrial level, probably by influencing oxidative phosphorylation. The importance of these new findings in regard to calcium homceostasis cannot yet be assessed. They provide a possible explanation for the failure to demonstrate the calcium-mobilizing effect of parathyroid hormone in states of vitamin D deficiency, although as pointed out, further proof that the unresponsiveness is real is still required.
Conclusion
The relationship ibetween parathyroid hormone and vitamin D, suspected for many years, has been confirmed by exciting new discoveries of effects on mitochondrial transport of calcium and phosphorus. These findings help to explain some of the metabolic effects of parathyroid hormone and vitamin D, and also the difficulties in proving whether differences between their actions exist. Since one of the primary effects of parathyroid hormone appears to be stimulation of uptake of phosphorus by mitochondria, it is appropriate to end with a prophetic remark by Albright, in 1948: "Parathyroid hormone may act primarily on phosphorus metabolism in some way which not only increases the excretion of phosphorus in the urine but a-lso produces certain bone changes directly." The accuracy of this prediction is now beginning to be apparent.
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